Answer
Jul 10, 2025 - 01:44 PM
Safinamide is a medication used as an adjunctive treatment for patients with Parkinson's disease. It works by inhibiting monoamine oxidase B (MAO-B) and modulating glutamate release, which helps to increase dopamine levels and improve motor symptoms in patients experiencing "off" episodes while on levodopa therapy. Safinamide is typically prescribed when patients require additional symptom management beyond what is achieved with their current regimen.
